"Designing Growth Strategies is in our DNA"
The global medical device cybersecurity solutions market size was valued at USD 1.46 billion in 2025. The market is projected to grow from USD 1.69 billion in 2026 to USD 5.68 billion by 2034, exhibiting a CAGR of 16.3% during the forecast period.
The global market comprises software platforms, embedded controls, monitoring technologies, and security services designed to protect connected medical devices, Internet of Medical Things (IoMT) assets, clinical networks, and device firmware. These solutions also protect associated data flows from unauthorized access, malware, ransomware, exploitation, and operational disruption. The market growth is attributed to the rapid expansion of connected clinical environments, persistent use of legacy and difficult-to-patch medical equipment, and rising ransomware exposure. Increasing regulatory scrutiny and the growing linkage between cybersecurity, patient safety, and continuity of care also contribute to market growth.
Furthermore, Claroty Ltd., Armis Security Ltd., Palo Alto Networks, Inc., Forescout Technologies, Inc., and Axonius, Inc. are among the prominent companies participating in the broader medical device and healthcare cyber-physical security ecosystem. Their positioning is supported by device visibility, clinical asset intelligence, network security, exposure management, behavioral monitoring, and integration with enterprise security workflows.
Increasing Shift Toward AI-driven, Context-aware, and Continuous Medical Device Security is Transforming Clinical Cybersecurity
Healthcare organizations are moving beyond periodic vulnerability scanning toward continuous, context-aware security models that combine medical device inventory, clinical criticality, communication behavior, vulnerability intelligence, and threat telemetry. AI/ML-supported analytics can establish expected device behavior, prioritize exposures based on operational and patient-care impact, and identify anomalous communications that conventional endpoint tools may miss. This shift is particularly important for medical devices that cannot support traditional security agents or cannot be routinely patched without disrupting clinical workflows. Cloud-delivered analytics and centralized security platforms are also helping multi-hospital systems consolidate visibility across distributed facilities while integrating medical-device risk into broader SOC, SIEM, NAC, firewall, and IT service-management processes.
Download Free sample to learn more about this report.
Rising Connected Medical Device Footprint and Cyber Risk to Drive Market Growth
The growing use of network-connected imaging systems, infusion pumps, patient monitors, diagnostic equipment, wearable devices, and software-enabled medical technologies is expanding the clinical attack surface. Many medical devices operate for long lifecycles, use legacy operating systems, communicate through specialized protocols, and cannot be patched or taken offline as easily as conventional IT endpoints. These characteristics increase the need for purpose-built asset discovery, risk prioritization, segmentation, virtual patching, behavioral monitoring, and threat detection. Cybersecurity investment is therefore increasingly treated as an element of patient safety and care continuity rather than solely as an IT compliance requirement. These factors are further contributing to the global medical device cybersecurity solutions market growth.
Market Drivers - Impact & CAGR Contribution (2026–2034)
| Rank | Market Driver | Overall Impact | CAGR Contribution, 2026–2034 | Impact: 2026-2028 | Impact: 2029-2031 | Impact: 2032-2034 |
|---|---|---|---|---|---|---|
| 1 | Rising cybersecurity threats, ransomware attacks, and vulnerability exposure across connected medical devices | High | 5.2% | High | High | High |
| 2 | Rapid expansion of connected medical devices, IoMT ecosystems, and digitally integrated healthcare infrastructure | High | 4.4% | High | High | High |
| 3 | Strengthening regulatory requirements and cybersecurity-by-design mandates for medical devices | High | 3.8% | High | High | High |
| 4 | Growing adoption of AI/ML-driven threat detection, behavioral analytics, and automated vulnerability management | Medium-High | 3.2% | Medium | High | High |
| 5 | Increasing adoption of cloud-based security, Zero Trust architecture, and real-time medical device monitoring | Medium | 2.8% | Medium | Medium | High |
| 6 | Others | Low | 2.0% | Low | Low | Low |
| Total Positive Growth Contribution | 21.40% | |||||
Source: Fortune Business Insights
Legacy Device Constraints, Budget Limitations, and Complex Clinical Environments May Restrict Adoption
Despite rising cybersecurity awareness, implementation can be constrained by fragmented device estates, limited biomedical engineering resources, competing hospital capital priorities, and the operational sensitivity of clinical equipment. Medical devices may remain in service for many years and often cannot accept standard endpoint agents or rapid software updates. Healthcare organizations must also integrate security controls without creating latency, device incompatibility, or interruptions to patient care. These factors can extend deployment cycles and increase the need for passive discovery, compensating controls, and carefully validated network segmentation.
Market Restraints - Impact & Negative CAGR Contribution (2026–2034)
| Rank | Market Restraints | Overall Impact | CAGR Contribution, 2026–2034 | Impact: 2026-2028 | Impact: 2029-2031 | Impact: 2032-2034 |
|---|---|---|---|---|---|---|
| 1 | Complexity of securing legacy medical devices and constraints associated with patching, upgrading, and device interoperability | High | -1.8% | High | High | Medium |
| 2 | High implementation costs and constrained cybersecurity budgets among healthcare organizations | High | -1.4% | High | Medium | Medium |
| 3 | Shortage of skilled healthcare cybersecurity professionals and complexity of integrating security without disrupting clinical workflows | Medium | -1.1% | Medium | Medium | Medium |
| 4 | Others | Low | -0.8% | Low | Low | Low |
| Total Negative Restraint Contribution | -5.10% | |||||
Source: Fortune Business Insights
Security-by-design, Embedded Protection, and Regulatory Compliance to Create Significant Opportunities
Increasing emphasis on security-by-design creates opportunities for cybersecurity vendors to work directly with medical device manufacturers during product development and post-market lifecycle management. Embedded runtime protection, firmware integrity monitoring, secure update mechanisms, software bill of materials management, vulnerability correlation, and device-native telemetry can reduce dependence on hospital-side controls alone. As regulatory expectations become more formalized, manufacturers and healthcare providers are likely to seek platforms that can support evidence generation, risk documentation, vulnerability remediation, and continuous monitoring across the device lifecycle.
Balancing Real-time Threat Response with Patient Safety and Device Availability Remains Challenging
Medical device cybersecurity teams must respond to threats while preserving the availability and clinical function of safety-critical equipment. Aggressive blocking, quarantine, or patching actions that are routine in enterprise IT may be inappropriate for devices supporting diagnosis, monitoring, or treatment. Security teams must therefore combine clinical context, device criticality, network behavior, vulnerability severity, and compensating controls before taking remediation action. Coordination among cybersecurity teams, clinical engineering, IT networking, device manufacturers, and care delivery teams remains essential.
Growing Need for Lifecycle Protection to Boost the Connected Medical Device Security Platforms Segment’s Growth
Based on the product type, the market is divided into connected medical device security platforms, medical device product security solutions, embedded & device-native security solutions, and cybersecurity services.
The connected medical device security platforms segment accounted for the largest share of the global market in 2025. The segment's dominance is attributed to the rapid proliferation of IoT-enabled and network-connected medical devices. Moreover, increasing device connectivity expands potential attack surfaces, elevating risks of ransomware, unauthorized access, and patient-data breaches. In addition, growing regulatory scrutiny and the need to protect legacy and unmanaged medical devices further support platform adoption globally.
The embedded & device-native security solutions segment is anticipated to grow with a CAGR of 19.4% over the forecast period.
To know how our report can help streamline your business, Speak to Analyst
Need for Complete Visibility of Connected Clinical Assets to Drive Device Discovery & Asset Management Segment’s Dominance
Based on application, the market is segmented into secure device development & premarket cybersecurity, device discovery & asset management, vulnerability & post-market risk management, runtime threat detection & incident response, network access control & segmentation, legacy & end-of-support device security, and others.
The device discovery & asset management segment held the leading share of the global market in 2025. Healthcare organizations frequently operate large and dynamic inventories of managed and unmanaged medical devices, making accurate identification a foundation for vulnerability management, segmentation, compliance, and incident response. Passive discovery, device fingerprinting, communication mapping, ownership attribution, and lifecycle visibility help security and clinical engineering teams identify previously unknown assets and establish a reliable medical-device inventory.
The runtime threat detection & incident response segment is anticipated to grow with a CAGR of 18.5% over the forecast period.
Deep Visibility into Clinical Communications to Propel Network & Protocol Intelligence Segment’s Leadership
Based on technology, the market is segmented into network & protocol intelligence, behavioral analytics & AI/ML, software composition & SBOM analytics, cryptography & trusted device identity, zero-trust & microsegmentation, security testing & attack simulation, and integrated multi-technology platforms.
The network & protocol intelligence segment accounted for the leading medical device cybersecurity solutions market share in 2025. Medical devices communicate using a combination of standard networking protocols and specialized clinical protocols, making network-level intelligence important for understanding device identity, communication pathways, dependencies, and potentially malicious activity. Passive network monitoring is especially valuable where installing agents on medical devices is impractical or prohibited.
The behavioral analytics & AI/ML segment is anticipated to grow with a CAGR of 19.0% over the forecast period.
Scalability and Centralized Analytics to Drive Cloud-based Segment’s Dominance
Based on deployment, the market is segmented into cloud-based, on-premise, and hybrid.
In 2025, the cloud-based segment dominated with the highest market share of 50.2%. Cloud delivery supports centralized asset intelligence, scalable analytics, rapid threat-intelligence updates, multi-site visibility, and integration with enterprise security platforms. It is particularly attractive to healthcare systems seeking to consolidate medical-device security across geographically distributed hospitals, clinics, and outpatient facilities.
The hybrid segment is anticipated to grow at a CAGR of 16.0% over the forecast period.
By region, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.
North America Medical Device Cybersecurity Solutions Market Size, 2025 (USD Billion)
To get more information on the regional analysis of this market, Download Free sample
North America held the dominant share in 2024, valued at USD 0.56 billion, and also maintained the leading share in 2025, with USD 0.67 billion. Growth is supported by extensive adoption of connected medical technologies, large healthcare networks, high data protection spending, active ransomware defense programs, and evolving regulatory expectations in the U.S. Healthcare providers are increasingly integrating medical-device visibility, exposure management, segmentation, and threat detection into broader enterprise security programs.
Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market can be analytically approximated at around USD 0.70 billion in 2026, accounting for roughly 41.5% of global sales.
Europe is projected to record a growth rate of 16.0% in the coming years and reach a valuation of USD 0.46 billion by 2026. The region is projected to witness strong growth during the forecast period as healthcare organizations modernize connected clinical infrastructure and medical device manufacturers respond to increasingly structured data privacy and product-security requirements.
The U.K. market size in 2026 is estimated at around USD 0.09 billion, representing roughly 5.4% of global revenues.
Germany’s market value is projected to reach approximately USD 0.10 billion by 2026, equivalent to around 6.2% of global sales.
Asia Pacific is estimated to reach USD 0.35 billion in 2026 and secure a significant position in the market. The region’s growth is driven by rapid connected-device adoption, healthcare digitalization, and increasing cybersecurity threats across hospital networks.
The Japan market size in 2026 is estimated at around USD 0.08 billion, accounting for roughly 4.8% of global revenues.
China’s market is projected to be one of the largest worldwide, with 2026 revenues estimated at around USD 0.11 billion, representing roughly 6.4% of global sales.
The Indian market value in 2026 is estimated at around USD 0.04 billion, accounting for roughly 2.5% of global revenues.
Latin America and the Middle East & Africa regions are expected to witness moderate growth in this market space during the forecast period. The Latin America market is set to reach a valuation of USD 0.06 billion by 2026, driven by expanding healthcare digitalization. Meanwhile, the Middle East & Africa region benefits from connected hospital infrastructure expansion and rising medical device data security awareness. In the Middle East & Africa region, the GCC market is set to reach a value of USD 0.02 billion by 2026.
The South Africa market size is projected to reach around USD 0.01 billion in 2026, representing roughly 0.7% of global revenues.
Platform Expansion, AI-enabled Exposure Management, and Healthcare-specific Capabilities to Strengthen Market Positioning
The global medical device cybersecurity solutions market has a competitive structure comprising specialized cyber-physical and IoMT security vendors alongside large enterprise cybersecurity companies. Prominent players include Claroty Ltd., Armis Security Ltd., Palo Alto Networks, Inc., Forescout Technologies, Inc., and Axonius, Inc. These companies compete through medical-device discovery, asset intelligence, vulnerability prioritization, behavioral monitoring, network segmentation, threat prevention, AI-enabled analytics, and integration with broader security and IT operations platforms.
Other notable players include Fortinet, Inc., Asimily, Inc., Ordr, Inc., Check Point Software Technologies Ltd., and Microsoft Corporation. Companies are expected to prioritize AI-driven risk prioritization, cloud-delivered security, healthcare-specific integrations, zero-trust segmentation, embedded protection, and partnerships with medical device manufacturers and healthcare delivery organizations.
The global medical device cybersecurity solutions market analysis includes a comprehensive study of the market size & forecast by all the market segments included in the report. It includes details on the market dynamics and market trends expected to drive the market over the forecast period. It provides information on key aspects, including an overview of technological advancements, the regulatory environment, and product launches. Additionally, it details partnerships, mergers & acquisitions, as well as key industry developments and investments by key regions. The global market research report also provides a deep competitive landscape with information on the market share and profiles of key operating players.
Request for Customization to gain extensive market insights.
| ATTRIBUTE | DETAILS |
| Study Period | 2021-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2021-2024 |
| Growth Rate | CAGR of 16.3% from 2026-2034 |
| Unit | Value (USD Billion) |
| Segmentation | By Product Type, Application, Technology, Deployment, and Region |
| By Product Type |
|
| By Application |
|
| By Technology |
|
| By Deployment |
|
| By Region |
|
Approach 1 - Country-Level Medical Device Cybersecurity Spending Analysis
Approach 2: Bottom-Up Installed Base & Cybersecurity Utilization Analysis
Approach 3: Credible Secondary Sources & Institutional Data Cross-Check
Approach 1: Revenues and Market Share of Major Players (2021-2025)
Approach 2: Triangulation, Validation and Forecast Modeling
Supply Side Interviews: 60%
According to Fortune Business Insights, the global market value stood at USD 1.46 billion in 2025 and is projected to reach USD 5.68 billion by 2034.
In 2025, the market value in North America stood at USD 0.67 billion.
The market is expected to exhibit a CAGR of 16.3% during the forecast period.
By product type, the connected medical device security platforms segment is expected to lead the market.
Growth is driven by expansion of connected medical devices, increasing ransomware and vulnerability exposure, legacy-device security constraints, regulatory requirements, and rising healthcare investment in cyber resilience.
Claroty Ltd., Armis Security Ltd., Palo Alto Networks, Inc., Forescout Technologies, Inc., and Axonius, Inc. are the major players in the global market.
North America dominated the market in 2025.
Get 30-60 hrs Free Customization
Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.
Related Reports
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )